miR-125a-3p reduces inflammation and restricts the proliferation of fibroblast-like synovial cells in rheumatoid arthritis by targeting MAST3 and regulating the Wnt/β-catenin and NF-κB signaling pathways (103). Here, NFKB1 is linked to rheumatoid arthritis.